h1

000851171 001__ 851171
000851171 005__ 20250815124034.0
000851171 0247_ $$2HSB$$aeva465046
000851171 0247_ $$2ISSN$$a2234-943X
000851171 0247_ $$2SCOPUS$$aSCOPUS:2-s2.0-85104253920
000851171 0247_ $$2WOS$$aWOS:000640331500001
000851171 0247_ $$2datacite_doi$$a10.18154/RWTH-CONV-248259
000851171 0247_ $$2doi$$a10.3389/fonc.2021.646883
000851171 0247_ $$2pmid$$apmid:33869041
000851171 037__ $$aRWTH-CONV-248259
000851171 041__ $$aEnglish
000851171 1001_ $$aLoosen, Sven H$$b0$$eCorresponding author
000851171 245__ $$aSerum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy$$honline
000851171 260__ $$aLausanne$$bFrontiers Media$$c2021
000851171 300__ $$a1-12
000851171 3367_ $$00$$2EndNote$$aJournal Article
000851171 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal
000851171 3367_ $$0PUB:(DE-HGF)7$$2PUB:(DE-HGF)$$aContribution to a book
000851171 3367_ $$2BibTeX$$aARTICLE
000851171 3367_ $$2DRIVER$$aarticle
000851171 3367_ $$2DataCite$$aOutput Types/Journal article
000851171 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000851171 536__ $$0G:(GEPRIS)403224013$$aSFB 1382 - SFB 1382: Die Darm-Leber-Achse - Funktionelle Zusammenhänge und therapeutische Strategien (403224013)$$c403224013$$x0
000851171 591__ $$aGermany
000851171 7001_ $$aGorgulho, Joao$$b1
000851171 7001_ $$aJördens, Markus S.$$b2
000851171 7001_ $$aSchulze-Hagen, Maximilian$$b3
000851171 7001_ $$aBeier, Fabian$$b4
000851171 7001_ $$aVucur, Mihael$$b5
000851171 7001_ $$0P:(DE-588)1155725603$$aSchneider, Anne Theres$$b6
000851171 7001_ $$aKoppe, Christiane$$b7
000851171 7001_ $$aMertens, Alexander$$b8
000851171 7001_ $$aKather, Jakob N.$$b9
000851171 7001_ $$0P:(DE-82)001476$$aTacke, Frank$$b10
000851171 7001_ $$aKeitel, Verena$$b11
000851171 7001_ $$0P:(DE-82)IDM06025$$aBrümmendorf, Tim Henrik$$b12
000851171 7001_ $$aRoderburg, Christoph$$b13
000851171 7001_ $$0P:(DE-82)016418$$aLuedde, Tom$$b14$$eCorresponding author
000851171 770__ $$aFactors determining long term anti-tumor responses to immune checkpoint blockade therapy
000851171 773__ $$0PERI:(DE-600)2649216-7$$a10.3389/fonc.2021.646883$$p646883$$tFrontiers in oncology$$v11$$x2234-943X
000851171 8564_ $$uhttps://publications.rwth-aachen.de/record/851171/files/851171.pdf$$yOpenAccess
000851171 909CO $$ooai:publications.rwth-aachen.de:851171$$popenaire$$popen_access$$pdriver$$pdnbdelivery$$pVDB
000851171 9141_ $$y2021
000851171 9151_ $$0StatID:(DE-HGF)0031$$2StatID$$aPeer reviewed article$$x0
000851171 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000851171 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-01-27
000851171 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT ONCOL : 2019$$d2021-01-27
000851171 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-27
000851171 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-27
000851171 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-27
000851171 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-27
000851171 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-27
000851171 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-27
000851171 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2021-01-27
000851171 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-01-27
000851171 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-01-27
000851171 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000851171 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2022-11-08
000851171 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2022-11-08
000851171 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2021-01-27
000851171 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2021-01-27
000851171 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bFRONT ONCOL : 2021$$d2022-11-08
000851171 9201_ $$0I:(DE-82)531040-2_20140620$$k531040-2$$lKlinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Onkologie und Hämatologie)$$x0
000851171 9201_ $$0I:(DE-82)531030-2_20140620$$k531030-2$$lKlinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Gastroenterologie und Stoffwechselkrankheiten)$$x1
000851171 961__ $$z2022-09-27
000851171 970__ $$aeva465046
000851171 9801_ $$aFullTexts
000851171 980__ $$aI:(DE-82)531030-2_20140620
000851171 980__ $$aI:(DE-82)531040-2_20140620
000851171 980__ $$aUNRESTRICTED
000851171 980__ $$aVDB
000851171 980__ $$acontb
000851171 980__ $$ajournal